New drug for Macular Degeneration

Genetech is currently studying a new drug, lampalizumab, to treat age-related macular degeneration. The drug is designed to slow the destruction of light-sensing cells in the retina. When those cells die, they are unable to regenerate, which causes permanent vision loss. 129 patients participated in the 18-month study and received monthly eye injections. The patients […]

Lutein levels in the eye linked to higher achievement in children

Two recent studies demonstrated that children who do better in school have higher lutein levels in the eye. Even after taking in consideration other factors including IQ, gender, body composition and physical fitness, children that had higher lutein levels did better on cognition tests and performed better academically. In the first study, researchers measured lutein […]

Optometrists more likely than ophthalmologists to recommend eye supplements

A recent study was conducted among Swedish optometrists and ophthalmologists that examined use of nutritional supplements, dietary advice, smoking and eye diseases and strength of evidence and the sources of information used for supplement recommendations. Optometrists responded at a much higher rate to the questionnaire used in the study at a rate of 40.3% compared […]

Will eyedrops replace injections for Macular Degeneration?

Researchers at the University of Birmingham have created a new eyedrop that can deliver wet macular degeneration treatment to the back of the eye. Macular degeneration causes damage to the retina at the back of the eye so this is why it is necessary for the medication to be focused on that area rather than […]

Eye disease screening recommendations

Adults who have no signs or risk factors for eye disease should get a baseline eye disease screening at age 40 according to recommendations by the American Academy of Ophthalmology. Age 40 is the age when early signs of eye disease and vision changes might begin to occur. The baseline screening will allow the ophthalmologist […]

Eye care providers not always detecting AMD

A recent study found that many times, primary eye care providers are missing cases of age-related macular degeneration. After reviewing data on 1,288 eyes in patients who received a dilated eye exam and who were not diagnosed with macular degeneration, researchers had retina specialists take another look and macular degeneration was diagnosed in 25 percent […]

#1 Cause of Vision Loss in Adults? Diabetes.

Diabetic retinopathy is the #1┬ácause of vision loss among working adults between the ages of 20 and 74 in the United States.* Lucentis recently gained FDA approval for monthly treatment of every form of diabetic retinopathy. This marks the first drug that the FDA has approved to treat diabetic retinopathy “with or without diabetic macular […]

Doctors successful retinal stem cell treatment

Doctors successfully transplanted retinal stem cells from a donor to the recipient in the first ever surgery of its type. Previously, doctors had performed a retinal stem cell┬átransplant back in 2014 using that patient’s own skin cells that were reprogrammed. That procedure was considered a success after a year with no decline in the patient’s […]

Eye injections increase glaucoma risk

Patients who receive seven or more Intravitreous eye injections of bevacizumab (Avastin) each year are at a higher risk of eventually needing glaucoma surgery according to study results recently published in the JAMA Ophthalmology medical journal. Intravitreous injections are the standard therapy for patients suffering from the wet form of macular degeneration. Researchers examined data […]

Some unproven stem cell treatments can cause blindness

Stem cell therapy is a hot topic in the news and the hope that stem cell therapy provides as a potential treatment for macular degeneration has resulted in clinics across the country providing unproven treatments. Recently, three elderly women underwent an unapproved stem cell therapy at a Florida clinic and within a week of receiving, […]